Earnings Call
Apr 29, 2026
Q1 FY2026
EPS Estimate
9.97
EPS Actual
10.31
Post-Earnings Close
$243.12
Earnings Reaction
+5.8%
Humana's first quarter 2026 results came in where management expected them to, and that framing, repeated deliberately by CEO Jim Rechtin, is itself the central message of the call. Rather than a beat-and-raise quarter, this was a quarter defined by execution against a multi-year recovery plan, with management focused on validating that the trajectory toward a sustainable 3% individual Medicare Advantage margin by 2028 remains intact. Early utilization indicators across risk scores, hospital admissions per thousand, pharmacy claims, and initial medical claims are running in line to slightly better than guidance, and that read-through extends into April. The company is maintaining full-year guidance.
Report generated on Apr 30, 2026
AI-generated earnings analysis. Not investment advice.
Chief Executive Officer
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
Read the full HUM analysis
The complete report, with key themes, analyst Q&A summary, notable quotes, and market context — is free with an account. No password, no card.